Company intelligence / Profile preview

Rapalogix Health

Carlsbad, California, United Statesrapalogix.com ↗
Ownership
Private
Development stage
Other
01

Overview

Rapalogix Health is a private biotechnology company focused on translating longevity science and mTOR biology into dermatology therapeutics and pro-longevity skin health products. The company is developing TORC1-selective compounds intended to address the biological drivers of skin aging and chronic skin disorders rather than only treating surface symptoms. Its lead commercial product is Re-Q Pro-Longevity Face Serum, powered by proprietary molecule RLX-201, and its lead prescription therapeutic candidate is RLX-202, which is in IND-enabling development for aesthetic dermatology and broader dermatologic applications. Rapalogix was spun out to apply Cambrian Bio's TORnado platform to skin health and is building a combined therapeutics-plus-professional-skincare business model. In June 2026, the company announced a $20 million Series A financing to expand Re-Q Health and advance its prescription pipeline.

Therapeutic areas
Dermatology
Modalities
Small moleculeProfessional skincare product
Industry
Biotech
02

Drug pipeline

2 assets

RLX-202

Unknown

1 more asset in the full pipeline.

Request access →
03

Partnerships

Cambrian BioDermatology physician partners

Beyond the preview

Go deeper on Rapalogix Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rapalogix Health.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call